AXQ Capital’s Day One Biopharmaceuticals DAWN Stock Holding History

AXQ Capital’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-12,147	Closed	-$260K	–	1069
2026 Q1	$260K	Sell	12,147 -20,258	-63%	-$285K	0.03%	641
2025 Q4	$302K	Buy	32,405 +16,099	+99%	+$134K	0.07%	440
2025 Q3	$115K	Buy	+16,306	New	+$112K	0.04%	507
2025 Q2	–	Sell	-19,030	Closed	-$151K	–	614
2025 Q1	$151K	Buy	+19,030	New	+$205K	0.06%	424
2024 Q4	–	Sell	-10,125	Closed	-$141K	–	484
2024 Q3	$141K	Buy	+10,125	New	+$144K	0.04%	394
2023 Q2	–	Sell	-23,070	Closed	-$308K	–	356
2023 Q1	$308K	Buy	+23,070	New	+$451K	0.12%	297

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

AXQ Capital's DAWN Position: Q2 2026 in Review

AXQ Capital sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 12,147 shares — an estimated $260K sold.

AXQ Capital first reported a position in DAWN in Q1 2023 and held it in 6 quarters. The position peaked at $308K in Q1 2023. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

AXQ Capital reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
AXQ Capital sold 12,147 Day One Biopharmaceuticals shares in Q2 2026, an estimated $260K.
AXQ Capital first reported a position in Day One Biopharmaceuticals in Q1 2023 and held it in 6 quarters.
AXQ Capital's Day One Biopharmaceuticals position peaked at $308K in Q1 2023.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.